Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

LL-37

Cathelicidin, hCAP-18, FALL-39, CAP-18

Quick Stats
Studies 2230
Trials 95
Score 2
2014 pubmed 44 citations

Human cathelicidin production by the cervix.

Frew. Lorraine L; Makieva. Sofia S; McKinlay. Andrew T M AT; McHugh. Brian J BJ; Doust. Ann A; Norman. Jane E JE; Davidson. Donald J DJ; Stock. Sarah J SJ

Key Findings

  • LL‑37 is detectable in cervicovaginal fluid and rises in bacterial vaginosis
  • Vitamin D metabolites (1,25‑OH‑D3 and 25‑OH‑D3) increase LL‑37 gene expression in cervical cell lines
  • Serum vitamin D levels do not correlate with LL‑37 levels in secretions
  • Synthetic LL‑37 triggers IL‑8 release, indicating pro‑inflammatory activity

Practical Outcomes

  • Vitamin D supplementation might modestly enhance local LL‑37 defenses in the female reproductive tract, but blood levels aren’t a reliable indicator. Directly using LL‑37 isn’t advisable due to its inflammatory effects. For biohackers, the main takeaway is that supporting vitamin D status could aid innate immunity in the cervix, though more research is needed before specific protocols.

Summary

The study shows that the antimicrobial peptide LL‑37 is naturally present in the cervix, especially when bacterial imbalance occurs, and that vitamin D forms can boost its production in cervical cells, though blood vitamin D levels don’t predict its amount. Adding synthetic LL‑37 makes cervical cells release inflammation signals, suggesting it can both help and hurt host defense.

Abstract

hCAP18/LL-37 is the sole human cathelicidin; a family of host defence peptides with key roles in innate host defence. hCAP18/LL-37 is expressed primarily by neutrophils and epithelial cells, but its production and function in the lower genital tract is largely uncharacterised. Despite the significant roles for cathelicidin in multiple organs and inflammatory processes, its impact on infections that could compromise fertility and pregnancy is unknown. The aim of this study was to investigate cathelicidin production, regulation and function in the cervix. hCAP18/LL-37 was found to be present in cervicovaginal secretions collected from women in the first trimester of pregnancy and to be expressed at significantly higher levels in samples from women with alterations in vaginal bacterial flora characteristic of bacterial vaginosis. In endocervical epithelial cell lines, expression of the gene encoding hCAP18/LL-37 (CAMP) was not affected by TLR agonists, but was found to be up-regulated by both 1, 25 hydroxyvitamin D3 and 25 hydroxyvitamin D3. However, no association was found between serum levels of vitamin D and hCAP18/LL-37 concentrations in cervicovaginal secretions (n = 116). Exposure to synthetic LL-37 had a pro-inflammatory effect on endocervical epithelial cell lines, increasing secretion of inflammatory cytokine IL-8. Together these data demonstrate inducible expression of hCAP18/LL-37 in the female lower reproductive tract in vivo and suggest the capacity for this peptide to modulate host defence to infection in this system. Further investigation will elucidate the effects of hCAP18/LL-37 on the physiology and pathophysiology of labour, and may lead to strategies for the prevention of infection-associated preterm birth.

Study Information

Provider

pubmed

Year

2014

Date

2014-08-04T00:00:00.000Z

DOI

10.1371/journal.pone.0103434

Citations

44

References

54